Josep Ferrer
Impact in
- Infectious Diseases top 10%
- SARS-CoV-2 detection and testing
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Pollution top 10%
- Pharmaceutical and Antibiotic Environmental Impacts
Papers in
-
- Antibiotic Use and Resistance 2
-
- Nosocomial Infections in ICU 2
- Co-authors
- David NavarroIgnacio TorresEliseo AlbertDixie HuntleyArantxa ValdiviaJavier ColominaMireia MartínezSandrine Poujois
In The Last Decade
Josep Ferrer
7 papers receiving 380 citations
Peers
Comparison fields: 5 of 65
- Infectious Diseases 216
- Pollution 105
- Health, Toxicology and Mutagenesis 56
- Biomedical Engineering 124
- Environmental Chemistry 26
Countries citing papers authored by Josep Ferrer
This map shows the geographic impact of Josep Ferrer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josep Ferrer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josep Ferrer more than expected).
Fields of papers citing papers by Josep Ferrer
This network shows the impact of papers produced by Josep Ferrer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josep Ferrer. The network helps show where Josep Ferrer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Josep Ferrer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 0 | |
| 4 | 2022 | 15 | |
| 5 | 2022 | 1 | |
| 6 | 2022 | 3 | |
| 7 | 2020 | 208 | |
| 8 | 2020 | 0 | |
| 9 | 2020 | 11 | |
| 10 | 2020 | 8 | |
| 11 | 2010 | 138 |
About Josep Ferrer
Josep Ferrer is a scholar working on Applied Microbiology and Biotechnology, Critical Care and Intensive Care Medicine, Infectious Diseases, Clinical Biochemistry and Epidemiology, having authored 11 papers that have together received 384 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (3 papers), Biosensors and Analytical Detection (3 papers), SARS-CoV-2 detection and testing (3 papers), Pneumonia and Respiratory Infections (2 papers), Antibiotic Use and Resistance (2 papers), Nosocomial Infections in ICU (2 papers), Viral gastroenteritis research and epidemiology (1 paper) and Infectious Diseases and Tuberculosis (1 paper). The work is most often cited by research in Infectious Diseases (216 citations), Pollution (105 citations), Health, Toxicology and Mutagenesis (56 citations), Biomedical Engineering (124 citations) and Environmental Chemistry (26 citations). Josep Ferrer has collaborated with scholars based in Spain and France. Frequent co-authors include David Navarro, Ignacio Torres, Eliseo Albert, Dixie Huntley, Arantxa Valdivia, Javier Colomina, Mireia Martínez, Sandrine Poujois, Lorena Forqué and Carlos Solano de la Asunción. Their work appears in journals such as Journal of Medical Virology, Diagnostic Microbiology and Infectious Disease, Clinical Microbiology and Infection, Frontiers in Pediatrics and Frontiers in Psychiatry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.